Literature DB >> 11136747

Rapid detection of smear-negative Mycobacterium tuberculosis by PCR and sequencing for rifampin resistance with DNA extracted directly from slides.

M Patnaik1, K Liegmann, J B Peter.   

Abstract

Conventional methods for identification of Mycobacterium tuberculosis from culture can take 6 weeks. To facilitate the rapid detection of M. tuberculosis and to assess the risks of drug resistance, we developed a technique of eluting DNA directly from sputum slides and performing PCR for the detection of M. tuberculosis DNA, followed by sequencing the rpoB gene to detect rifampin resistance. This entire process requires only 48 h. Forty-seven sputum specimens submitted for microscopy for detection of acid-fast bacilli (AFB) and for mycobacterial culture and susceptibility testing were assessed after elution from the slides and extraction. M. tuberculosis-specific DNA was amplified in a nested PCR with previously described primers (primers rpo95-rpo293 and rpo105-rpo273), followed by analysis on a 4% agarose gel for a 168-bp product. Automated sequencing was performed, and the sequences were aligned against a database for detection of anomalies in the rpoB gene (codons 511 to 533) which indicate rifampin resistance. Of the 47 sputum specimens tested, 51% (24 of 47) were culture positive (time to positive culture, 2 to 6 weeks). Smears for AFB were positive for 58% (14 of 24) of the specimens and were negative for 42% (10 of 24) of the specimens. All 24 culture-positive sputum specimens (14 microscopy-positive and 10 microscopy-negative sputum specimens) were positive by PCR with eluates from the smears. Forty-nine percent (23 of 47) of the sputum specimens were negative for M. tuberculosis by smear, culture, and PCR. Of the isolates from the culture-positive samples, five were rifampin resistant by sequencing; all five were also rifampin resistant by in vitro susceptibility testing. Of these rifampin-resistant M. tuberculosis isolates, two were microscopy negative for AFB. Patients who are negative for AFB and culture positive for M. tuberculosis can now be identified within a day, allowing institution of therapy and reducing isolation time and medical costs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11136747      PMCID: PMC87678          DOI: 10.1128/JCM.39.1.51-52.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Single-tube balanced heminested PCR for detecting Mycobacterium tuberculosis in smear-negative samples.

Authors:  A García-Quintanilla; L Garcia; G Tudó; M Navarro; J González; M T Jiménez de Anta
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

Review 2.  Drug-resistant tuberculosis: what do we do now?

Authors:  A Telenti; M Iseman
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 3.  Molecular methods in the detection and identification of mycobacterial infections.

Authors:  G L Woods
Journal:  Arch Pathol Lab Med       Date:  1999-11       Impact factor: 5.534

4.  Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.

Authors:  A Telenti; P Imboden; F Marchesi; D Lowrie; S Cole; M J Colston; L Matter; K Schopfer; T Bodmer
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

5.  Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas.

Authors:  V Kapur; L L Li; S Iordanescu; M R Hamrick; A Wanger; B N Kreiswirth; J M Musser
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

6.  Direct genotypic detection of Mycobacterium tuberculosis rifampin resistance in clinical specimens by using single-tube heminested PCR.

Authors:  A C Whelen; T A Felmlee; J M Hunt; D L Williams; G D Roberts; L Stockman; D H Persing
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

7.  Direct detection of Mycobacterium tuberculosis in sputum by polymerase chain reaction and DNA hybridization.

Authors:  F S Nolte; B Metchock; J E McGowan; A Edwards; O Okwumabua; C Thurmond; P S Mitchell; B Plikaytis; T Shinnick
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

8.  Detection of Mycobacterium tuberculosis in clinical samples by two-step polymerase chain reaction and nonisotopic hybridization methods.

Authors:  R M Shawar; F A el-Zaatari; A Nataraj; J E Clarridge
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

9.  Large-scale use of polymerase chain reaction for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory.

Authors:  J E Clarridge; R M Shawar; T M Shinnick; B B Plikaytis
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

10.  Utility of PCR in diagnosing pulmonary tuberculosis.

Authors:  J Bennedsen; V O Thomsen; G E Pfyffer; G Funke; K Feldmann; A Beneke; P A Jenkins; M Hegginbothom; A Fahr; M Hengstler; G Cleator; P Klapper; E G Wilkins
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

View more
  11 in total

1.  Rapid identification of mycobacteria and drug-resistant Mycobacterium tuberculosis by use of a single multiplex PCR and DNA sequencing.

Authors:  Ailyn C Pérez-Osorio; David S Boyle; Zachary K Ingham; Alla Ostash; Romesh K Gautom; Craig Colombel; Yolanda Houze; Brandon T Leader
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

2.  Use of DNA extracts from Ziehl-Neelsen-stained slides for molecular detection of rifampin resistance and spoligotyping of Mycobacterium tuberculosis.

Authors:  A G M Van Der Zanden; E M Te Koppele-Vije; N Vijaya Bhanu; D Van Soolingen; L M Schouls
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

3.  Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR.

Authors:  Mercedes Marín; Darío García de Viedma; María Jesús Ruíz-Serrano; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

4.  Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis.

Authors:  Olga L Sarmiento; Kristen A Weigle; Janet Alexander; David J Weber; William C Miller
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

5.  Direct detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis in auramine-rhodamine-positive sputum specimens by real-time PCR.

Authors:  Maite Ruiz; Maria J Torres; Ana C Llanos; Aurelio Arroyo; Jose C Palomares; Javier Aznar
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

6.  Rapid detection of rpoB mutations in rifampin resistant M. tuberculosis from sputum samples by denaturing gradient gel electrophoresis.

Authors:  Jun Li; Jiaojiao Xin; Liyuan Zhang; Longyan Jiang; Hongcui Cao; Lanjuan Li
Journal:  Int J Med Sci       Date:  2012-01-11       Impact factor: 3.738

7.  Multidrug-resistant tuberculosis detection, Latvia.

Authors:  Girts Skenders; Alicia M Fry; Inga Prokopovica; Silvija Greckoseja; Lonija Broka; Beverly Metchock; Timothy H Holtz; Charles D Wells; Vaira Leimane
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

8.  In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-analysis and meta-regression.

Authors:  Laura L Flores; Madhukar Pai; John M Colford; Lee W Riley
Journal:  BMC Microbiol       Date:  2005-10-03       Impact factor: 3.605

9.  A rapid and sensitive system for recovery of nucleic acids from Mycobacteria sp. on archived glass slides.

Authors:  Balkis A Talip; William J Snelling; Roy D Sleator; Colm Lowery; James S G Dooley
Journal:  BMC Microbiol       Date:  2018-11-26       Impact factor: 3.605

10.  Detection of drug resistant Mycobacterium tuberculosis by high-throughput sequencing of DNA isolated from acid fast bacilli smears.

Authors:  Mazhgan Rowneki; Naomi Aronson; Peicheng Du; Paige Sachs; Robert Blakemore; Soumitesh Chakravorty; Shawn Levy; Angela L Jones; Geetika Trivedi; Sheilla Chebore; Dennis Addo; Denis K Byarugaba; Panganani Dalisani Njobvu; Frederick Wabwire-Mangen; Bernard Erima; Eric S Ramos; Carlton A Evans; Braden Hale; James D Mancuso; David Alland
Journal:  PLoS One       Date:  2020-05-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.